. 2017 Dec 7;8(70):114506–114525. doi: 10.18632/oncotarget.23016

Table 1. Effects of CAPE and CAPE-pNO₂ treatment on blood urea nitrogen, serum creatinine, 24 h albumin, triglyceride and cholesterol in diabetic mice.

	Control Group	Diabetes Group	Diabetes + Treatment Group
	Control Group	Diabetes Group	CAPE(20 μmol/kg)	CAPE-pNO₂(20 μmol/kg)	CAPE-pNO₂(40 μmol/kg)
sCr (μmol/L)	46.26 ± 9.09	95.96 ± 2.74^#	59.73 ± 1.98^*	54.38 ± 2.04^*	43.42 ± 4.79^*&
BUN (mmol/L)	8.02 ± 0.42	15.16 ± 1.55^#	12.12 ± 0.24^*	11.12 ± 1.23^*	10.67 ± 0.98^*
Alb (mg/24h)	1.31 ± 0.03	18.19 ± 0.44^#	12.16 ± 0.53^*	10.15 ± 0.42^*+	6.68 ± 0.31^*&
TC (mmol/L)	3.22 ± 0.11	4.44 ± 0.06^#	3.43 ± 0.20^*	3.32 ± 0.16^*	3.09 ± 0.05^*&
TG (mmol/L)	0.77 ± 0.02	2.73 ± 0.10^#	1.87 ± 0.39^*	1.73 ± 0.05^*+	1.36 ± 0.03^*&

Data are expressed as mean ± SD, n ≥ 6. ^#p < 0.05 vs. control group; ^*p < 0.05 vs. diabetes group; ⁺p < 0.05 vs. CAPE group; ^&p < 0.05 vs. Low-CAPE-pNO₂ group.

Table 1. Effects of CAPE and CAPE-pNO2 treatment on blood urea nitrogen, serum creatinine, 24 h albumin, triglyceride and cholesterol in diabetic mice.

Table 1. Effects of CAPE and CAPE-pNO₂ treatment on blood urea nitrogen, serum creatinine, 24 h albumin, triglyceride and cholesterol in diabetic mice.